Eliot has more than 25 years of experience in the pharmaceutical and biotechnology industry and previously served as Chief Executive Officer of Immunocore from 2015. Prior to that he was Chief Executive Officer of biotechnology companies Creabilis Therapeutics (now Sienna Biopharmaceuticals) and Solace Pharmaceuticals Inc. Other previous roles include Head of Development and Operations for the EU and Asia at Pfizer. Eliot is Non-Executive Chairman of Avacta PLC and of MedCity, which promotes the Life Sciences in the “Golden Triangle”, and founding Chairman of Advanced Oxford, which aims to grow the innovation economy in the Oxford region. He is an Honorary Visiting Professor of the Pharmacology and Physiology Department at the University of Liverpool, a Board member of OSCHR (Office for Strategic Coordination of Health Research) and the National Genomics Board. He holds a PhD from University of Liverpool and an MBA from Henley Management College.